Latest Breaking News On - Richard fosbeary - Page 1 : comparemela.com

STORM Therapeutics to Present Data on its First-in-Class METTL1 tRNA Methyltransferase Inhibitors at AACR Annual Meeting 2024

STORM Therapeutics to Present Data on its First-in-Class METTL1 tRNA Methyltransferase Inhibitors at AACR Annual Meeting 2024
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United statesUnited kingdomSan diegoAlexandra sapetschnigMatthew fyfeNatalie websterKonstantinos tzelepisBeth thomasJack roganRichard fosbearySarah bucknellEliza yankovaAleksandra azevedoOsian evansOliver rauschByron andrews

STORM Therapeutics To Present Data On Its First-In-Class METTL1 Trna Methyltransferase Inhibitors At AACR Annual Meeting 2024

STORM Therapeutics To Present Data On Its First-In-Class METTL1 Trna Methyltransferase Inhibitors At AACR Annual Meeting 2024
menafn.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from menafn.com Daily Mail and Mail on Sunday newspapers.

United statesUnited kingdomSan diegoSarah bucknellKonstantinos tzelepisJack roganAlexandra sapetschnigMatthew fyfeHarry fischlEliza yankovaRichard fosbearyNatalie websterBeth thomasOliver rauschOsian evansAleksandra azevedo

STORM Therapeutics Ltd: STORM Therapeutics to Present Data on its First-in-Class METTL1 tRNA Methyltransferase Inhibitors at AACR Annual Meeting 2024

STORM Therapeutics Ltd: STORM Therapeutics to Present Data on its First-in-Class METTL1 tRNA Methyltransferase Inhibitors at AACR Annual Meeting 2024
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.

United statesUnited kingdomSan diegoHarry fischlOliver rauschByron andrewsDennis riedlOsian evansEliza yankovaAleksandra azevedoSarah bucknellRichard fosbearyBeth thomasJack roganKonstantinos tzelepisNatalie webster

STORM Therapeutics to Present Data on its First-in-Class METTL1 tRNA Methyltransferase Inhibitors at AACR Annual Meeting 2024

Late breaking presentation on STORM’s METTL1 inhibitors, for the treatment of cancer, on 8 April 2024 26 March 2024, Cambridge, UK: STORM Therapeutics Ltd. (STORM), the clinical stage biotechnology company discovering and developing novel small molecule therapies targeting RNA modifying enzymes (RMEs) for.

San diegoUnited statesUnited kingdomSarah bucknellOsian evansEliza yankovaAleksandra azevedoRichard fosbearyAlexandra sapetschnigHarry fischlJack roganNatalie websterMatthew fyfeBeth thomasOliver rauschByron andrews

STORM Therapeutics to Present Findings on its First-in-Class METTL1 tRNA Methyltransferase Inhibitors at ESMO Targeted Anticancer Therapies Congress

STORM Therapeutics to Present Findings on its First-in-Class METTL1 tRNA Methyltransferase Inhibitors at ESMO Targeted Anticancer Therapies Congress
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.

United kingdomFrance generalSarah bucknellHarry fischlHall bordeauxRichard fosbearyJack roganOliver rauschEliza yankovaKonstantinos tzelepisByron andrewsBeth thomasAlexandra sapetschnigAleksandra azevedoOsian evansMatthew fyfe